Skip to main content
News > Blog > Bioresearch Collaboration Will Speed Development of New Therapies and Mitigate High Drug Prices

Bioresearch Collaboration Will Speed Development of New Therapies and Mitigate High Drug Prices

This fall, Open Therapeutics (OT) expects to debut an elegant platform that will allow scientists and researchers to collaborate on all aspects of Bioresearch and development. University researchers who have conducted exhaustive research on treatments for disease, yet find themselves stifled by isolation, will be able to team up with other like-minded researchers to share data and results. When breakthroughs are reached, each researcher will be able to produce papers that complement the research of others, all the while receiving appropriate recognition for their own work. The beneficiaries will not only be scientists, but also the public, which has struggled for years with the high cost of treatments and drugs.

Open Therapeutics will bring together pools of university researchers, corporations, non-profits, entrepreneurs, and inventors who may be focusing on the same bio problem.
Scott Wager (Follow Him on Twitter @WagersScott) writes in his insightful article 20 Benefits of Collaboration As a Researcher You Cannot Afford to Ignore that it all begins with the benefits of collaboration….

  • Higher impact publications: There is a direct correlation between the number of authors and impact factor. Not much more needs to be said. This is probably more a reflection of the fact that good science requires the combined efforts of many good scientists.
  • Knowledge of what others are doing: You can read papers or look at patent filings, yet there is no better way to know what others are doing than talking to them. In industry and in research it is always best to be where everyone else is.
  • Early adopters: Your collaboration partners are almost by definition your early adopters for your novel approach, new technology, or new hypothesis. You can also think about it as the best way to foster paradigm shift. It all begins with a dedicated group of core believers.
  • Impressing investors: That what you are doing is accepted by a group of leaders in the field is no better argument for convincing investors. This is also true for funding agencies.

All researchers will now have access to a web portal service that reduces the cost and risk of developing and deploying therapeutics. By stimulating an economies of scale model and micro-pharma indigenous industries, the global population should experience lower prices and greater availability of life-saving drugs.

We Believe

Open Therapeutics crowdsources orphan and dormant therapeutic intellectual properties (IP) to scientists around the world. The goal is advancing research that ordinarily has not generated a public value or been recognized. This approach particularly helps underserved scientists to collaborate with their more financially capable colleagues.

How open science helps researchers succeed:

Open access, open data, open source, and other open scholarship practices are growing in popularity and necessity. However, widespread adoption of these practices has not yet been achieved. One reason is that researchers are uncertain about how sharing their work will affect their careers.

The review of the literature demonstrates that open science is associated with increases in citations, media attention, potential collaborators, job opportunities, and funding opportunities. These findings are evidence that open science practices bring significant benefits to researchers relative to more traditional closed practices.

Secured By miniOrange